- The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
- Find out how study types differ in our How to read a paper section.
- Impact factor latest: The BMJ's impact factor is now 17.215. Submit your paper to the world's fourth most cited general medical journal.
- OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.
- Keep up to date with diabetes: Access the latest diabetes resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
- Hot topics: We regularly publish more than one article on the same subject simultaneously. Find out more on our article clusters page.
- Dementia: Access the latest dementia resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Neurology updates: Access the latest neurology resources from BMJ Group, including articles, learning modules, podcasts, and blogs.
- Infectious diseases: Access the latest infectious disease resources from across BMJ Group, including articles, learning modules, podcasts, and blogs.
- Updates from bmj.com: Get RSS feeds of latest articles published at bmj.com/rss
Douglas Kamerow is a family doctor and specialist in preventive medicine and works as a chief scientist at RTI International, a large not-for-profit research company. He also teaches medical students and family medicine residents at Georgetown University as a clinical professor of family medicine. He is an associate editor of the BMJ, writing a column on health policy, called Yankee Doodling. He spent 20 years in the US Public Health Service, leading a range of clinical, health policy, and research activities and retiring as an Assistant Surgeon General in 2001. He had key leadership roles in the US Preventive Services Task Force, the Evidence-based Practice Centers, and other programs that have advanced evidence-based care. Dr Kamerow is a graduate of Harvard College, the University of Rochester Medical School, and Johns Hopkins University School of Public Health. He is board-certified in family medicine and preventive medicine.
Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ?
Reimbursement for attending a symposium?
A fee for speaking?
A fee for organising education?
Funds for research?
My research has been funded by the Robert Wood Johnson foundation, Smith Family Foundation, and Partnership for Prevention. None has a financial interest in publishing in the BMJ.
Funds for a member of staff?
Fees for consulting?
My consulting has been sponsored by the Institute of Medicine and Partnership for Prevention. Neither has a financial interest in publishing in the BMJ.
Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ?
I work for RTI, a not-for-profit research company. They don't stand to gain or lose financially from the publication of papers in the BMJ.
Do you hold any stocks or shares in an organisation?
Yes, but except for small holdings in General Motors and Apple Computer, they are all in mutual funds or under investment manager control, so I don't select the stocks.
Do you have any other competing financial interests?
I have no competing interests.